Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Pfizer
Turning Point Therapeutics, Inc.
Replimune Inc.
Avenzo Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Auricula Biosciences Inc.
DualityBio Inc.
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Marengo Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Cancer Research UK
Evopoint Biosciences Inc.